BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37271284)

  • 1. GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling.
    Lin YF; Li MH; Huang RH; Zhang SZ; Xu XF; Zhou HM; Liu MH; Liao XX; Liao LZ; Guo Y; Zhuang XD
    Int J Cardiol; 2023 Sep; 387():131109. PubMed ID: 37271284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM64 promotes ox-LDL-induced foam cell formation, pyroptosis, and inflammation in THP-1-derived macrophages by activating a feedback loop with NF-κB via IκBα ubiquitination.
    Zhu C; Chen W; Cui H; Huang Z; Ding R; Li N; Wang Q; Wu F; Zhao Y; Cong X
    Cell Biol Toxicol; 2023 Jun; 39(3):607-620. PubMed ID: 36229750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
    Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
    Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
    Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
    Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A.
    Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y
    Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL.
    Song J; Yang S; Yin R; Xiao Q; Ma A; Pan X
    J Cell Biochem; 2019 Aug; 120(8):13640-13650. PubMed ID: 30938884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
    Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
    FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
    Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
    Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
    J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FNDC5/PPARa Pathway Alleviates THP-1-derived Macrophage Pyroptosis and Its Mechanism.
    Zhou B; Zhao G; Li H; Zhao Q; Liu D
    Altern Ther Health Med; 2023 Apr; 29(3):32-42. PubMed ID: 36689357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway.
    Zhang H; Gong X; Ni S; Wang Y; Zhu L; Ji N
    Int Immunopharmacol; 2019 Dec; 77():105934. PubMed ID: 31727560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelargonic acid vanillylamide and rosuvastatin protect against oxidized low-density lipoprotein-induced endothelial dysfunction by inhibiting the NF-κB/NLRP3 pathway and improving cell-cell junctions.
    Sivasinprasasn S; Wikan N; Tocharus J; Chaichompoo W; Suksamrarn A; Tocharus C
    Chem Biol Interact; 2021 Aug; 345():109572. PubMed ID: 34217687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
    Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
    Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A and interleukin -1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway.
    Jia X; Liu Z; Wang Y; Li G; Bai X
    Atherosclerosis; 2023 Jun; 375():87-97. PubMed ID: 36935311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0007478 aggravates NLRP3 inflammasome activation and lipid metabolism imbalance in ox-LDL-stimulated macrophage via miR-765/EFNA3 axis.
    Ye B; Liang X; Zhao Y; Cai X; Wang Z; Lin S; Wang W; Shan P; Huang W; Huang Z
    Chem Biol Interact; 2022 Dec; 368():110195. PubMed ID: 36191606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB/ABCA1 pathway aggravates ox-LDL-induced cell pyroptosis by activation of NLRP3 inflammasomes in THP-1-derived macrophages.
    Li J; Liu J; Yu Y; Liu Y; Guan X
    Mol Biol Rep; 2022 Jul; 49(7):6161-6171. PubMed ID: 35579737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE
    Du X; Jiang S; Zeng X; Zhang J; Pan K; Zhou J; Xie Y; Kan H; Song W; Sun Q; Zhao J
    Toxicol Lett; 2018 Jun; 290():123-132. PubMed ID: 29571893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
    Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
    J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
    Yan J; Li M; Wang XD; Lu ZY; Ni XL
    Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.
    Jia X; Bai X; Yang X; Wang L; Lu Y; Zhu L; Zhao Y; Cheng W; Shu M; Mei Q; Jin S
    Metabolism; 2022 Oct; 135():155274. PubMed ID: 35917895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.